Download PDF
CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2020; 24(04): e423-e428
DOI: 10.1055/s-0039-3402431
Original Research

Effect of Vitamin D Injection in Recurrent Benign Paroxysmal Positional Vertigo with Vitamin D Deficiency

Gu Il Rhim 
1   The One Otorhinolaryngology Clinic, Paju, South Korea
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Introduction There have been reports indicating that patients with frequently recurring benign paroxysmal positional vertigo (BPPV) had vitamin D deficiency, and some studies indicated that the treatment of severe vitamin D deficiency is effective in the reduction of the recurrence of BPPV.

Objective The purpose of the present study was to examine the effects of Vitamin D3 injection on recurrence among patients with a 10 ng/mL or lower 25-hydroxyvitamin D blood concentration diagnosed with BPPV.

Methods Among 99 patients with idiopathic BPPV with vitamin D deficiency, 25 patients (case group) were submitted to 3 to 4 injections of 200,000 IU of vitamin D3 in the first year. In total, 50 patients in the control group were selected through frequency matching, with 25 patients in the case group. Age, gender, and type of BPPV are used in matching variables with 1:2 matched data. The subjects of the study group were followed up for 24 months.

Results The differences in relapse rates between the case and the control groups were examined using the non-parametric Kruskal-Wallis test for k independent samples. With regard to the relapse rates of the entire case and control groups by period, from 0 to 6 months (p < 0.531), from 7 to 12 months (p < 1.000), and from 13 to 24 months (p < 0.711), and in the entire study period (p < 0.883) there were no statistically significant differences.

Conclusion The present case-control study indicated that vitamin D3 injection had no significant effect on the recurrence of BPPV patients with vitamin D deficiency when age, gender, and type of BPPV were homogeneous between the two groups.

Keywords

benign paroxysmal positional vertigo - vitamin D deficiency - recurrence


Publication History

Received: 10 November 2018

Accepted: 10 October 2019

Article published online:
07 February 2020

© .

Thieme Revinter Publicações Ltda
Rio de Janeiro, Brazil

 

  • References

  • 1 Tanimoto H, Doi K, Nishikawa T, Nibu K. Risk factors for recurrence of benign paroxysmal positional vertigo. J Otolaryngol Head Neck Surg 2008; 37 (06) 832-835
    Google Scholar
  • 2 Sakaida M, Takeuchi K, Ishinaga H, Adachi M, Majima Y. Long-term outcome of benign paroxysmal positional vertigo. Neurology 2003; 60 (09) 1532-1534
    CrossrefPubMedGoogle Scholar
  • 3 Brandt T, Huppert D, Hecht J, Karch C, Strupp M. Benign paroxysmal positioning vertigo: a long-term follow-up (6-17 years) of 125 patients. Acta Otolaryngol 2006; 126 (02) 160-163
    CrossrefPubMedGoogle Scholar
  • 4 Lundberg YW, Xu Y, Thiessen KD, Kramer KL. Mechanisms of otoconia and otolith development. Dev Dyn 2015; 244 (03) 239-253
    CrossrefPubMedGoogle Scholar
  • 5 Rhim GI. Serum vitamin D and recurrent benign paroxysmal positional vertigo. Laryngoscope Investig Otolaryngol 2016; 1 (06) 150-153
    CrossrefPubMedGoogle Scholar
  • 6 Xu Y, Zhang H, Yang H, Zhao X, Lovas S, Lundberg YW. Expression, functional, and structural analysis of proteins critical for otoconia development. Dev Dyn 2010; 239 (10) 2659-2673
    CrossrefPubMedGoogle Scholar
  • 7 Lundberg YW, Zhao X, Yamoah EN. Assembly of the otoconia complex to the macular sensory epithelium of the vestibule. Brain Res 2006; 1091 (01) 47-57
    CrossrefPubMedGoogle Scholar
  • 8 Vibert D, Kompis M, Häusler R. Benign paroxysmal positional vertigo in older women may be related to osteoporosis and osteopenia. Ann Otol Rhinol Laryngol 2003; 112 (10) 885-889
    CrossrefPubMedGoogle Scholar
  • 9 Yamanaka T, Shirota S, Sawai Y, Murai T, Fujita N, Hosoi H. Osteoporosis as a risk factor for the recurrence of benign paroxysmal positional vertigo. Laryngoscope 2013; 123 (11) 2813-2816
    CrossrefPubMedGoogle Scholar
  • 10 Jeong SH, Choi SH, Kim JY, Koo JW, Kim HJ, Kim JS. Osteopenia and osteoporosis in idiopathic benign positional vertigo. Neurology 2009; 72 (12) 1069-1076
    CrossrefPubMedGoogle Scholar
  • 11 Jeong SH, Kim JS, Shin JW. et al. Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol 2013; 260 (03) 832-838
    CrossrefPubMedGoogle Scholar
  • 12 Talaat HS, Abuhadied G, Talaat AS, Abdelaal MSS. Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo. Eur Arch Otorhinolaryngol 2015; 272 (09) 2249-2253
    CrossrefPubMedGoogle Scholar
  • 13 Büki B, Ecker M, Jünger H, Lundberg YW. Vitamin D deficiency and benign paroxysmal positioning vertigo. Med Hypotheses 2013; 80 (02) 201-204
    CrossrefPubMedGoogle Scholar
  • 14 Talaat HS, Kabel AMH, Khaliel LH, Abuhadied G, El-Naga HAER, Talaat AS. Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency. Auris Nasus Larynx 2016; 43 (03) 237-241
    CrossrefPubMedGoogle Scholar
  • 15 Pérez P, Franco V, Cuesta P, Aldama P, Alvarez MJ, Méndez JC. Recurrence of benign paroxysmal positional vertigo. Otol Neurotol 2012; 33 (03) 437-443
    CrossrefPubMedGoogle Scholar
  • 16 von Brevern M, Radtke A, Lezius F. et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry 2007; 78 (07) 710-715
    CrossrefPubMedGoogle Scholar
  • 17 Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997; 337 (10) 670-676
    CrossrefPubMedGoogle Scholar
  • 18 Mosekilde L. Vitamin D and the elderly. Clin Endocrinol (Oxf) 2005; 62 (03) 265-281
    CrossrefPubMedGoogle Scholar
  • 19 Gülşah ÇI, Yunsur Ç, Emine E, Şeref KÇ. Analysis of Vitamin D and Calcium Levels in Benign Paroxysmal Positional Vertigo. Eurasian J Emerg Med 2017; 16: 128-132
    CrossrefGoogle Scholar
  • 20 Karataş A, Acar Yüceant G, Yüce T, Hacı C, Cebi IT, Salviz M. Association of Benign Paroxysmal Positional Vertigo with Osteoporosis and Vitamin D Deficiency: A Case Controlled Study. J Int Adv Otol 2017; 13 (02) 259-265
    CrossrefPubMedGoogle Scholar
  • 21 AlGarni MA, Mirza AA, Althobaiti AA, Al-Nemari HH, Bakhsh LS. Association of benign paroxysmal positional vertigo with vitamin D deficiency: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol 2018; 275 (11) 2705-2711
    CrossrefPubMedGoogle Scholar
  • 22 Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69 (05) 842-856
    CrossrefPubMedGoogle Scholar
  • 23 Choi HS, Chung YS, Choi YJ, Seo DH, Lim SK. Efficacy and safety of vitamin D3 B.O.N intramuscular injection in Korean adults with vitamin D deficiency. Osteoporos Sarcopenia 2016; 2 (04) 228-237
    CrossrefPubMedGoogle Scholar
  • 24 Hansen KE, Erin Johnson R, Chambers KR. et al. Treatment of vitamin D insufficiency in postmenopausal women: a randomized clinical trial. JAMA Intern Med 2015; 175 (10) 1612-1621
    CrossrefPubMedGoogle Scholar
  • 25 De Stefano A, Dispenza F, Suarez H. et al. A multicenter observational study on the role of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo. Auris Nasus Larynx 2014; 41 (01) 31-36
    CrossrefPubMedGoogle Scholar
  • 26 Ogun OA, Janky KL, Cohn ES, Büki B, Lundberg YW. Gender-based comorbidity in benign paroxysmal positional vertigo. PLoS One 2014; 9 (09) e105546
    CrossrefPubMedGoogle Scholar